Skip to content

Oral Glucose Tolerance Testing After Gestational Diabetes

Oral Glucose Tolerance Testing After Gestational Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02082301
Enrollment
118
Registered
2014-03-10
Start date
2012-10-31
Completion date
2019-12-31
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes, Obesity, Pregnancy

Brief summary

This is an observation study of women with gestational diabetes. Subjects recruited undergo immediate postpartum diabetic screening prior to discharge. Post-partum screening for overt diabetes is repeated 6-12 weeks postpartum. The outcome of interest is the utility of an immediate post partum screen for overt diabetes compared to a traditional 6 week test.

Interventions

None listed

Sponsors

Centers for Disease Control and Prevention
CollaboratorFED
Loyola University
CollaboratorOTHER
MetroHealth Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Singleton pregnancy * Gestational diabetes

Exclusion criteria

* Multiple gestations * pre-pregnancy diabetes

Design outcomes

Primary

MeasureTime frameDescription
Primary outcome: sensitivity of immediate post partum screenImmediate post partum2 hour fasting 75g OGTT immediately post partum. This is compared to a traditional 6 week post partum 75g OGTT for the sensitivity, positive and negative predictive value of the immediate post partum test

Secondary

MeasureTime frameDescription
Secondary outcome: physiology3 time points: antepatum, immediate postpartum, 6 weeks post partumA small sub-cohort of women will undergo an additional 2 hour fasting 75g OGTT in the third trimester with measurements of insulin, cytokines, lipids.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026